Medical Research
(H300)
990 on File
INTERNATIONAL TRANSPLANT-SKIN CANCER COLLABORATIVE
Financial strength (30%)
69/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$126K
Total Revenue
$87K
Total Expenses
$174K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
100.0%
Fundraising Efficiency
N/A
Operating Reserve
24.03x
Liability-to-Asset
22.6%
Revenue Diversification
35.2%
Executive Compensation
$0
Compared with Peers
FY 2024
Compared with 782 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
100.0% | 78.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
24.0 mo | 38.9 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
22.6% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
35.2% | 100.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
91.8% | -0.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
97.8% | -6.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
31.0% | 15.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $126K | $87K | $174K | 100.0% | — |
| 2023 | $66K | $44K | $135K | 100.0% | — |
| 2022 | $77K | $75K | $113K | 100.0% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.